Clinical Trials Browser

Phase 2 × Icrucumab × Gastrointestinal × Clear all

NCT01111604 2019-08-06

A Study of Ramucirumab or Icrucumab in Colorectal Cancer

Phase 2 Completed

158 enrolled 17 charts

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Rectal Neoplasms